Brett Matthew Hall
CHIEF SCIENTIFIC OFFICER · Immuneering Corp
- 2025
- Jun 16, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Brett Matthew Hall files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Thomas J. Schall - $101K in IMRX purchases and sales in the last 12 months
- Peter Feinberg - $87K in IMRX purchases and sales in the last 12 months
- Harold Eugene Brakewood - $25K in IMRX purchases and sales in the last 12 months
- Benjamin J. Zeskind - $11K in IMRX purchases and sales in the last 12 months
- Leah R. Neufeld - $11K in IMRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Brett Matthew Hall?
Brett Matthew Hall is a corporate insider, tracked as CHIEF SCIENTIFIC OFFICER of Immuneering Corp (IMRX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Brett Matthew Hall last file a Form 4?
The most recent primary Form 4 on record is dated 16 June 2026, one of 4 filings going back to 2025.
Has Brett Matthew Hall been buying or selling stock?
Recorded transactions: 2 open-market purchases ($36K) and 0 open-market sales across all tracked filings.
